Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Oxylipins as Biomarkers for Aromatase Inhibitor-Induced Arthralgia (AIA) in Breast Cancer Patients.
Journal: Metabolites
Published: March 03, 2023
Feasibility Trial to Evaluate Tendon Stiffness Obtained from Shear Wave Elastography Imaging as a Biomarker of Aromatase Inhibitor-Induced Arthralgias.
Journal: Journal of clinical medicine
Published: January 07, 2022
Metformin and an insulin/IGF-1 receptor inhibitor are synergistic in blocking growth of triple-negative breast cancer.
Journal: Breast cancer research and treatment
Published: August 28, 2020
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Journal: Breast cancer research and treatment
Published: May 30, 2019
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2019
Unbiased Lipidomic Profiling of Triple-Negative Breast Cancer Tissues Reveals the Association of Sphingomyelin Levels with Patient Disease-Free Survival.
Journal: Metabolites
Published: May 01, 2018
Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 02, 2016
Metformin in breast cancer - an evolving mystery.
Journal: Breast cancer research : BCR
Published: June 27, 2015
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: June 25, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026